Zimmer Biomet’s Strategic Transformation Pivots to Active Portfolio Management

Zimmer Biomet

Zimmer Biomet reported 3Q20 orthopedic revenue of USD $1,729.1 million, +2.9% vs. 3Q19. The company observed mixed recovery dynamics during the third quarter, as it returned to growth faster than expected but also saw the rate of recovery flatten by September. Zimmer Biomet performed especially well in the U.S., where its knee franchise grew...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us